27/03/2008
Infant Cough Medicines Pulled From Shelves
A number of cough and cold remedies aimed at very young children are being removed from shop shelves due to concerns over accidental overdoses.
The Medicine and Healthcare Regulatory Agency (MHRA) has ordered that six products - Asda Children's Chesty Cough Syrup; Boots Chesty Cough Syrup 1 Year Plus; Boots Sore Throat and Cough Linctus 1 Year Plus; Buttercup Infant Cough Syrup; CalCough Chesty; and Children's Chesty Cough - be removed from sale for children aged under two.
However, the regulator said that the medicines could still be supplied under the supervision of a pharmacist for older children.
More remedies will also be taken off the shelves so that they can be repackaged to include advice that they should not be given to children aged under two.
Until these changes can be made, the medicines will be kept behind chemist counters and anyone asking for them will be questioned about the age of the children who is ill, before the product is sold.
The move follows concerns about certain medicines in the US after parents gave children the wrong dose or more than one product containing the same ingredient.
The ingredients which have caused the concerns are: brompheniramine, chlorphenamine, diphenhydramine, dextromethorphan, pholcodine, guaifenesin, ipecacuanha, phenylephrine, pseudoephedrine, ephedrine, oxymetazoline and xylometazoline.
MHRA spokesperson Sara Coakley said: "It's a precautionary measure. They are not dangerous.
"If they had been dangerous, we'd have had them off the market in seconds. Nobody should panic. There's nothing wrong with these medicines, it was the way that they had been given."
Ms Coakley said that the medicines could be dangerous if a child was given more than the recommended dose or were given more than one product at the same time.
She said: "Children under two are particularly susceptible because of their small size so can be at risk of overdose."
She admitted that there had been an increase in "adverse reactions" to the products, but said that they had been more widely observed in the US where improved packaging had since been introduced.
Parents are being advised instead to treat children suffering from a cold with paracetamol or ibuprofen in order to lower their temperature and to use a simple cough syrup, such as glycerol, honey or lemon. Nasal saline drops are recommended to help thin and clear nasal secretions in young babies, who have difficulty feeding as a result of being ill.
Vapour rubs and inhalant decongestants, which can be applied to a child's clothing, can also be used to provide relief from a stuffy nose.
(KMcA)
The Medicine and Healthcare Regulatory Agency (MHRA) has ordered that six products - Asda Children's Chesty Cough Syrup; Boots Chesty Cough Syrup 1 Year Plus; Boots Sore Throat and Cough Linctus 1 Year Plus; Buttercup Infant Cough Syrup; CalCough Chesty; and Children's Chesty Cough - be removed from sale for children aged under two.
However, the regulator said that the medicines could still be supplied under the supervision of a pharmacist for older children.
More remedies will also be taken off the shelves so that they can be repackaged to include advice that they should not be given to children aged under two.
Until these changes can be made, the medicines will be kept behind chemist counters and anyone asking for them will be questioned about the age of the children who is ill, before the product is sold.
The move follows concerns about certain medicines in the US after parents gave children the wrong dose or more than one product containing the same ingredient.
The ingredients which have caused the concerns are: brompheniramine, chlorphenamine, diphenhydramine, dextromethorphan, pholcodine, guaifenesin, ipecacuanha, phenylephrine, pseudoephedrine, ephedrine, oxymetazoline and xylometazoline.
MHRA spokesperson Sara Coakley said: "It's a precautionary measure. They are not dangerous.
"If they had been dangerous, we'd have had them off the market in seconds. Nobody should panic. There's nothing wrong with these medicines, it was the way that they had been given."
Ms Coakley said that the medicines could be dangerous if a child was given more than the recommended dose or were given more than one product at the same time.
She said: "Children under two are particularly susceptible because of their small size so can be at risk of overdose."
She admitted that there had been an increase in "adverse reactions" to the products, but said that they had been more widely observed in the US where improved packaging had since been introduced.
Parents are being advised instead to treat children suffering from a cold with paracetamol or ibuprofen in order to lower their temperature and to use a simple cough syrup, such as glycerol, honey or lemon. Nasal saline drops are recommended to help thin and clear nasal secretions in young babies, who have difficulty feeding as a result of being ill.
Vapour rubs and inhalant decongestants, which can be applied to a child's clothing, can also be used to provide relief from a stuffy nose.
(KMcA)
Related UK National News Stories
Click here for the latest headlines.
07 July 2006
Whooping cough 'endemic' among school children
Nearly 40% of school age children in the UK who visit their doctor with a persistent cough have evidence of whooping cough infection, even though they have been fully immunised, a study has claimed.
Whooping cough 'endemic' among school children
Nearly 40% of school age children in the UK who visit their doctor with a persistent cough have evidence of whooping cough infection, even though they have been fully immunised, a study has claimed.
17 August 2004
New plans to focus on providing better medicines for children
A new initiative to encourage the development of more medicines designed specifically for use in children has been announced today by the government. The new paediatric medicines strategy is aimed at encouraging manufacturers of medicines to research and develop medicines geared to the needs of children.
New plans to focus on providing better medicines for children
A new initiative to encourage the development of more medicines designed specifically for use in children has been announced today by the government. The new paediatric medicines strategy is aimed at encouraging manufacturers of medicines to research and develop medicines geared to the needs of children.
03 September 2015
Pregnant Women Urged To Get Whooping Cough Vaccine
Pregnant women are being encouraged to take up the whooping cough (pertussis) vaccine, after new figures revealed the disease remains at increased levels in England. Published today, the data for the year to March 2015, shows whooping cough vaccine coverage in pregnant women averaged 56.4% in England.
Pregnant Women Urged To Get Whooping Cough Vaccine
Pregnant women are being encouraged to take up the whooping cough (pertussis) vaccine, after new figures revealed the disease remains at increased levels in England. Published today, the data for the year to March 2015, shows whooping cough vaccine coverage in pregnant women averaged 56.4% in England.
01 February 2013
January Sees Further Fall In Whooping Cough Cases
Health Protection Agency figures for England and Wales show that whooping cough cases have slowed over the last two months. It follows the largest outbreak for 20 years. In December 832 cases were recorded, almost half the total from October. During the outbreak 14 babies died, the last death coming in December.
January Sees Further Fall In Whooping Cough Cases
Health Protection Agency figures for England and Wales show that whooping cough cases have slowed over the last two months. It follows the largest outbreak for 20 years. In December 832 cases were recorded, almost half the total from October. During the outbreak 14 babies died, the last death coming in December.
28 September 2012
Pregnant Women To Be Offered Whooping Cough Vaccine
A new whooping cough vaccine is to be offered to pregnant women across the UK, in an effort to protect babies from an escalating outbreak of the disease. It is known that very young babies are at the greatest risk of serious complications. Ten have died in the UK so far this year.
Pregnant Women To Be Offered Whooping Cough Vaccine
A new whooping cough vaccine is to be offered to pregnant women across the UK, in an effort to protect babies from an escalating outbreak of the disease. It is known that very young babies are at the greatest risk of serious complications. Ten have died in the UK so far this year.